Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03559088 · ClinicalTrials.gov registry record · NA
A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (App) on Participant Care
A NA study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT03559088 is a NA study that has completed, run by Eli Lilly and Company. The registered enrollment target is 120 participants.
The verdict
NCT03559088, a NA study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether using a smart phone application to foster communication between study participants and their doctor will impact care. Participants must have a history of migraine or have recently been prescribed a common medicine to treat migraine. The study will last about one year for each participant.
Interventions
- OTHER Migraine App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2018-06-11 |
| Est. Completion | 2019-04-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03559088
The ClinicalTrials.gov registry entry for NCT03559088 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Migraine App is the first listed.
NCT03559088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03559088 about?
NCT03559088 is a clinical study titled "A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (App) on Participant Care". The purpose of this study is to determine whether using a smart phone application to foster communication between study participants and their doctor will impact care. Participants must have a history of migraine or have recently been prescribed a common medicine to treat migraine. The study will la...
What is the current status of trial NCT03559088?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2018-06-11. Estimated completion is 2019-04-26.
What interventions are being tested in trial NCT03559088?
The interventions under investigation include: Migraine App (OTHER).
Who is sponsoring clinical trial NCT03559088?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.